Withdrawal of Infliximab or Concomitant Immunosuppressant Therapy in Patients With Crohn's Disease on Combination Therapy (SPARE): A Multicentre, Open-Label, Randomised Controlled Trial
The Lancet Gastroenterology & Hepatology（2023）
摘要
European Union's Horizon 2020.
更多查看译文
关键词
concomitant immunosuppressant therapy,crohn,infliximab,combination therapy,withdrawal,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要